Tower Research Capital (TRC)’s Black Diamond Therapeutics BDTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $52.2K | Buy |
21,031
+14,410
| +218% | +$35.7K | ﹤0.01% | 2934 |
|
|
2025
Q1 | $10.3K | Sell |
6,621
-1,659
| -20% | -$2.57K | ﹤0.01% | 3662 |
|
|
2024
Q4 | $17.7K | Sell |
8,280
-4,063
| -33% | -$8.7K | ﹤0.01% | 3290 |
|
|
2024
Q3 | $53.7K | Buy |
12,343
+11,303
| +1,087% | +$49.2K | ﹤0.01% | 2682 |
|
|
2024
Q2 | $4.85K | Sell |
1,040
-4,121
| -80% | -$19.2K | ﹤0.01% | 4740 |
|
|
2024
Q1 | $26.2K | Buy |
5,161
+569
| +12% | +$2.89K | ﹤0.01% | 2764 |
|
|
2023
Q4 | $12.9K | Sell |
4,592
-3,258
| -42% | -$9.16K | ﹤0.01% | 4003 |
|
|
2023
Q3 | $22.5K | Buy |
7,850
+5,734
| +271% | +$16.5K | ﹤0.01% | 3269 |
|
|
2023
Q2 | $10.7K | Sell |
2,116
-5,511
| -72% | -$27.8K | ﹤0.01% | 4057 |
|
|
2023
Q1 | $15K | Buy |
7,627
+4,162
| +120% | +$8.19K | ﹤0.01% | 3764 |
|
|
2022
Q4 | $6K | Sell |
3,465
-810
| -19% | -$1.4K | ﹤0.01% | 4681 |
|
|
2022
Q3 | $7K | Sell |
4,275
-180
| -4% | -$295 | ﹤0.01% | 4868 |
|
|
2022
Q2 | $11K | Buy |
4,455
+897
| +25% | +$2.22K | ﹤0.01% | 4351 |
|
|
2022
Q1 | $10K | Sell |
3,558
-7,691
| -68% | -$21.6K | ﹤0.01% | 4276 |
|
|
2021
Q4 | $60K | Buy |
11,249
+8,845
| +368% | +$47.2K | ﹤0.01% | 2618 |
|
|
2021
Q3 | $20K | Buy |
2,404
+457
| +23% | +$3.8K | ﹤0.01% | 3697 |
|
|
2021
Q2 | $24K | Buy |
1,947
+463
| +31% | +$5.71K | ﹤0.01% | 3715 |
|
|
2021
Q1 | $36K | Sell |
1,484
-955
| -39% | -$23.2K | ﹤0.01% | 3392 |
|
|
2020
Q4 | $78K | Sell |
2,439
-11,701
| -83% | -$374K | ﹤0.01% | 2588 |
|
|
2020
Q3 | $427K | Buy |
14,140
+11,644
| +467% | +$352K | ﹤0.01% | 1858 |
|
|
2020
Q2 | $105K | Buy |
+2,496
| New | +$105K | ﹤0.01% | 2406 |
|